Maar wat weten we van dit nieuwe middel
Acute pancreatitis has been reported with GLP-1 agonists, and FDA labeling recommends discontinuing the medication if pancreatitis is suspected
Therefore, it is conceivable that Receptor Grade IGF-1 LR3 may manifest an even greater anabolic capacity than IGF-1, according to multiple comparative studies on the anabolic properties of IGF-1
An observational Indian study in GLP-1 users reported that about 4 in 10 people experienced GI side effects, with nausea being the most common, followed by vomiting, diarrhoea, and constipation
Combining four compounds compounds the uncertainty: potential interactions, cumulative immunogenicity, and effects of long-term exposure are all unstudied
Chan AC: Partners in defense, vitamin E and vitamin